Securian Asset Management Inc. Reduces Holdings in Option Care Health, Inc. (NASDAQ:OPCH)

Securian Asset Management Inc. decreased its position in Option Care Health, Inc. (NASDAQ:OPCH) by 3.3% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 12,865 shares of the company’s stock after selling 433 shares during the period. Securian Asset Management Inc.’s holdings in Option Care Health were worth $298,000 at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. UMB Bank n.a. boosted its position in shares of Option Care Health by 41.7% during the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock worth $27,000 after purchasing an additional 346 shares during the period. Quarry LP boosted its position in shares of Option Care Health by 327.7% during the 3rd quarter. Quarry LP now owns 3,430 shares of the company’s stock worth $107,000 after purchasing an additional 2,628 shares during the period. Blue Trust Inc. boosted its position in shares of Option Care Health by 16.9% during the 4th quarter. Blue Trust Inc. now owns 4,703 shares of the company’s stock worth $109,000 after purchasing an additional 681 shares during the period. Venturi Wealth Management LLC boosted its position in shares of Option Care Health by 2,621.3% during the 4th quarter. Venturi Wealth Management LLC now owns 4,735 shares of the company’s stock worth $110,000 after purchasing an additional 4,561 shares during the period. Finally, KBC Group NV boosted its position in shares of Option Care Health by 16.2% during the 3rd quarter. KBC Group NV now owns 5,013 shares of the company’s stock worth $157,000 after purchasing an additional 700 shares during the period. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Insider Activity

In related news, insider Michael Bavaro sold 30,996 shares of Option Care Health stock in a transaction on Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the sale, the insider now directly owns 44,974 shares in the company, valued at $1,495,835.24. This trade represents a 40.80 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 0.64% of the company’s stock.

Option Care Health Price Performance

Shares of OPCH opened at $34.33 on Wednesday. Option Care Health, Inc. has a twelve month low of $21.39 and a twelve month high of $34.85. The firm’s fifty day simple moving average is $31.22 and its 200-day simple moving average is $28.25. The firm has a market capitalization of $5.68 billion, a price-to-earnings ratio of 28.85, a PEG ratio of 2.30 and a beta of 1.33. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77.

Analysts Set New Price Targets

A number of research firms recently weighed in on OPCH. JMP Securities reaffirmed a “market outperform” rating and set a $30.00 price objective (down previously from $31.00) on shares of Option Care Health in a research report on Friday, January 10th. JPMorgan Chase & Co. raised their price target on shares of Option Care Health from $40.00 to $41.00 and gave the company an “overweight” rating in a research report on Thursday, March 6th. Barrington Research raised their price target on shares of Option Care Health from $33.00 to $38.00 and gave the company an “outperform” rating in a research report on Thursday, February 27th. Jefferies Financial Group raised shares of Option Care Health from a “hold” rating to a “buy” rating and raised their price target for the company from $26.00 to $35.00 in a research report on Thursday, January 23rd. Finally, Bank of America raised shares of Option Care Health from a “neutral” rating to a “buy” rating and raised their price target for the company from $26.00 to $33.00 in a research report on Monday, January 13th. Two investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $33.00.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.